Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
SARS-CoV-2 Drug Discovery
Jump to section
- Article
- Abstract
- Introduction
- Overview of SARS-CoV-2 Genome and Protein Constituents
- Viral Entry Through the Binding of SARS-CoV-2 Spike Proteins to Angiotensin Converting Enzyme 2 Receptor
- SARS-CoV-2 Has Multiple Viral Entry Mechanisms
- Drug Development Strategies
- SARS-CoV-2 Viral Entry Inhibitors
- Viral Replication Inhibitors
- Host Cell and Viral Targets for Antiviral Drug Development
- Prophylactic Treatment of SARS-CoV-2 Infection
- Other Treatments in Clinical Trials for COVID-19
- Vaccines for SARS-CoV-2
- Perspectives and Conclusion
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters